The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2011

Filed:

Mar. 12, 2007
Applicants:

Abraham Scaria, Framingham, MA (US);

Peter Pechan, Brookline, MA (US);

Samuel Wadsworth, Shrewsbury, MA (US);

Inventors:

Abraham Scaria, Framingham, MA (US);

Peter Pechan, Brookline, MA (US);

Samuel Wadsworth, Shrewsbury, MA (US);

Assignee:

Genzyme Corporation, Framingham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/04 (2006.01); C12N 15/00 (2006.01); C12N 9/48 (2006.01); A61K 38/17 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

Multimeric fusion proteins of an Ig-like domain of Flt-1 are rendered functional by inclusion of a linker moiety. Vectors encoding the fusion proteins and host cells expressing the fusion proteins can be used therapeutically to block neovascularization in individuals with pathological conditions related to neovascularization. Such conditions include age-related macular degeneration, cancer, psoriasis, proliferative diabetic retinopathy, asthma, uveitis, osteoarthritis, and rheumatoid arthritis. The same means of multimerization used for an Iglike domain of Flt-1, i.e., a linker and a multimerization domain, can be used for other polypeptides, including extracellular receptors, antibody variable regions, cytokines, chemokines, and growth factors.


Find Patent Forward Citations

Loading…